Clinical Development Lead, Solid Tumor Oncology, BTC & GEA

Job Description

We are looking for a Clinical Development Lead specializing in Solid Tumor Oncology, specifically focusing on BTC (Biliary Tract Cancer) and GEA (Gastroesophageal Adenocarcinoma) to join Jazz Pharmaceuticals. As the Clinical Development Lead, you will be responsible for driving the strategic direction and leadership of the clinical development of a key Oncology asset for BTC and GEA, from late-stage development through to commercialization.

Responsibilities

• Provide strategic leadership for the clinical development of the Oncology program aligning with corporate goals.
• Develop and execute comprehensive global clinical development plans for Oncology in the context of BTC and GEA.
• Collaborate with cross-functional teams to ensure seamless execution of clinical development programs.
• Oversee the execution of clinical trials, ensuring compliance with regulatory requirements.
• Analyze clinical trial data, interpret results, and identify risks and mitigation strategies.
• Foster external collaborations to enhance scientific exchange and advance the oncology pipeline.
• Manage budget allocation and resource planning for clinical development programs.
• Foster high-performance culture and provide mentorship to team members.

Requirements

• Demonstrable experience leading the development of Solid Tumor Oncology assets successfully through late-stage development.
• Proven experience in leading high-performing clinical development teams.
• Executive presence to effectively communicate complex insights to executive-level audiences.
• MD required, Board certified Oncologist preferred.
• Higher postgraduate degree e.g., PhD preferred.
• Clinical and/or development experience in Solid Tumor Oncology, such as BTC or Gastrointestinal cancers preferred.

Jazz Pharmaceuticals is an equal opportunity employer. US-based candidates can expect competitive compensation packages.